Cancer Cause and Prevention Research in New Hampshire
Cancer Cause and Prevention Research (93.393) awarded $14.0 million to recipients in New Hampshire in 11 grants from fiscal 2021 to 2025, 0.4% of the program's national total. Trustees of Dartmouth College received the most, $7.4 million.
- Awarded in New Hampshire$14.0 million
- Awards11
- Share of the program0.4%
- Rank among states34th of 48
- National total$3.6 billion
By year
| Fiscal year | Awards | Amount |
|---|---|---|
| FY 2021 | 7 | $3.5 million |
| FY 2022 | 6 | $3.1 million |
| FY 2023 | 5 | $2.1 million |
| FY 2024 | 6 | $3.2 million |
| FY 2025 | 4 | $1.9 million |
Recipients in New Hampshire
| Recipient | Type | Awards | Amount |
|---|---|---|---|
| Trustees of Dartmouth College | Colleges and universities | 7 | $7.4 million |
| Dartmouth-Hitchcock Clinic | Nonprofits | 2 | $3.5 million |
| Insight Surgical Technologies Inc. | Small businesses | 1 | $2.0 million |
| Cairnsurgical, Inc. | Small businesses | 1 | $992,343 |
Open opportunities under this program
- Secondary Analysis and Integration of Existing Data to Elucidate Cancer Risk and Related Outcomes (R01 Clinical Trial Not Allowed)
- Secondary Analysis and Integration of Existing Data to Elucidate Cancer Risk and Related Outcomes (R21 Clinical Trials Not Allowed)
- Academic Research Enhancement Award (AREA) for Undergraduate-Focused Institutions (R15 Clinical Trial Required)
- Cancer Prevention and Control Clinical Trials Grant Program (R01 Clinical Trial Required)
- National Cancer Institute's Investigator-Initiated Early Phase Clinical Trials for Cancer Treatment and Diagnosis (R01 Clinical Trial Required)
- Mechanisms that Impact Cancer Risk with Use of Incretin Mimetics (R01 Clinical Trial Optional)
- Mechanisms that Impact Cancer Risk with Use of Incretin Mimetics (R21 Clinical Trial Not Allowed)
- HEAL Initiative: Studies to Enable Analgesic Discovery (R61/R33 - Clinical Trial Not Allowed)
- Carcinogen Hazard Assessment Monographs Program (CHAMP) (R01 Clinical Trial Not Allowed)
- NIH, CDC and FDA Small Business Innovation Research Grant (Parent SBIR [R43/R44] Clinical Trial Optional)
See all 60 on the program page
Questions people ask
How much Cancer Cause and Prevention Research money goes to New Hampshire?
$14.0 million from fiscal 2021 to 2025, across 11 awards. New Hampshire ranks 34th of 48 states and territories for this program.
Who receives Cancer Cause and Prevention Research money in New Hampshire?
The largest recipient is Trustees of Dartmouth College, with $7.4 million in 7 awards. Next are Dartmouth-Hitchcock Clinic and Insight Surgical Technologies Inc..
Can organizations in New Hampshire apply now?
Yes, 60 opportunities under this program are open or forecast on Grants.gov. Federal grants are national, so eligibility depends on the notice, not the state.
Cancer Cause and Prevention Research in other states
Other large programs in New Hampshire
- Grants to States for Medicaid
- Highway Planning and Construction
- Education Stabilization Fund
- Disaster Grants - Public Assistance (Presidentially Declared Disasters)
- Special Education Grants to States
- Children's Health Insurance Program
- Drinking Water State Revolving Fund
- Title I Grants to Local Educational Agencies
- National School Lunch Program
- Low-Income Home Energy Assistance